(Q37444118)

English

Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction

scientific article published on 23 July 2009

Statements

Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction (English)
Timothy D Henry
Douglas E Vaughan
James T Willerson
Emerson C Perin
Antonis K Hatzopoulos
David H McKenna
Doris A Taylor
Christopher R Cogle
Rachel E Olson
Beth C Jorgenson
Shelly L Sayre
Rachel W Vojvodic
David J Gordon
Sonia I Skarlatos
Lemuel A Moye'
Robert D Simari
Cardiovascular Cell Therapy Research Network (CCTRN)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit